<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04693728</url>
  </required_header>
  <id_info>
    <org_study_id>1054</org_study_id>
    <nct_id>NCT04693728</nct_id>
  </id_info>
  <brief_title>Adaptive Strategies for Resilient Intrinsic Self-Regulation in Extremes (RISE)</brief_title>
  <acronym>RISE</acronym>
  <official_title>Adaptive Strategies for Resilient Intrinsic Self-Regulation in Extremes (RISE): A Controlled Clinical Trial as an Intervention for Chronic Pain From a Homeostatic Perspective</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phoenix VA Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phoenix VA Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy of a resilience intervention in Veterans&#xD;
      with chronic pain compared to wait list control.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After being consented and screened for eligibility, participants completed baseline&#xD;
      assessments and then were randomized to either the study intervention or wait list control.&#xD;
      Participants who were randomized to the study intervention completed post testing assessment&#xD;
      measures within two weeks of the final treatment. Participants who were randomized to&#xD;
      waitlist conditions completed post testing assessment measures within 2 weeks of the end of&#xD;
      the waitlist condition and then subsequently received the study intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 13, 2014</start_date>
  <completion_date type="Actual">October 1, 2020</completion_date>
  <primary_completion_date type="Actual">October 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RAND 36-item Health Survey (SF-36) - Mental Health and Physical Health subscales</measure>
    <time_frame>2 weeks</time_frame>
    <description>assessment of positive emotional health</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PTSD Check List-5</measure>
    <time_frame>2 weeks</time_frame>
    <description>assessment of PTSD symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Health Questionnaire, Depression Scale (PHQ-9)</measure>
    <time_frame>2 weeks</time_frame>
    <description>assessment of depression symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Generalized Anxiety Disorder (GAD-7)</measure>
    <time_frame>2 weeks</time_frame>
    <description>assessment of anxiety symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Catastrophizing Scale</measure>
    <time_frame>2 weeks</time_frame>
    <description>assessment of pain catastrophizing symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physical Symptoms Scale (PHQ-15)</measure>
    <time_frame>2 weeks</time_frame>
    <description>assessment of physical symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insomnia Severity Index</measure>
    <time_frame>2 weeks</time_frame>
    <description>assessment of insomnia symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>West Haven-Yale Multidimensional Pain Inventory (WYMPI)</measure>
    <time_frame>2 weeks</time_frame>
    <description>multidimensional assessment of pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Outcomes Questionnaire (POQ)</measure>
    <time_frame>2 weeks</time_frame>
    <description>multidimensional assessment of pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological Assessment Battery (NAB) - Word Generation subtest</measure>
    <time_frame>2 weeks</time_frame>
    <description>neuropsychological assessment of executive functions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Delis-Kaplan Executive Function System (D-KEFS) - Category Fluency, Category Switching, and Color-Word Switching subtests</measure>
    <time_frame>2 weeks</time_frame>
    <description>neuropsychological assessement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)</measure>
    <time_frame>2 weeks</time_frame>
    <description>neuropsychological assessment of working memory, episodic memory, and complex attention</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Behavioral Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The study intervention arm was a behavioral treatment that consisted of training resilient intrinsic self-regulation strategies to help alleviate chronic pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait-list with no treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control comparison arm consisted of a wait-list condition in which participants received no treatment during a time interval comparable to the intervention arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Resilient Intrinsic Self-Regulation Strategies in Extremes</intervention_name>
    <description>The manualized intervention covered resilience strategies organized into four modules: (1) engagement, (2) social relatedness, (3) transformation of pain and (4) building a good life. The modules were delivered in 8 weekly sessions of 90 minutes each.</description>
    <arm_group_label>Behavioral Intervention</arm_group_label>
    <other_name>Active Intervention arm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1.18-80 years of age 2. United States Veterans from the conflicts of OEF/OIF to Vietnam era&#xD;
        3. Self-identified chronic pain or chart diagnosis of chronic pain&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Active suicidality of suicidal intent requiring a greater than outpatient level of&#xD;
             care (Columbia Suicidality Rating Scale screen, C-SSRS)&#xD;
&#xD;
          2. Active alcohol abuse (Alcohol Use Disorder Identification Test, AUDIT-C)&#xD;
&#xD;
          3. Active psychosis (Psychosis Screener)&#xD;
&#xD;
          4. Current severe disabling illness&#xD;
&#xD;
          5. Inability to participate in a small group interactive setting&#xD;
&#xD;
          6. Inability to meet attendance requirement&#xD;
&#xD;
          7. Neurocognitive conditions other than TBI (e.g. dementia, Parkinsons, stroke)&#xD;
&#xD;
          8. Concurrently receiving Exposure Therapy, Cognitive Behavior Therapy, Acceptance and&#xD;
             Commitment Therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martha Kent, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Phoenix VAHCS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Phoenix VA Health Care System</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 23, 2020</study_first_submitted>
  <study_first_submitted_qc>December 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>December 30, 2020</last_update_submitted>
  <last_update_submitted_qc>December 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Phoenix VA Health Care System</investigator_affiliation>
    <investigator_full_name>Aram Mardian</investigator_full_name>
    <investigator_title>Senior Research Scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

